Blueprint Medicines Reports Second Quarter 2022 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LRCX
6. LVS
7. SAP
8. CSX
9. KNX
10. SPY

Go back to Blueprint Medicines Reports Second Quarter 2022 Results

Blueprint Medicines (BPMC) Misses Q2 EPS by 44c

August 2, 2022 7:06 AM EDT

Blueprint Medicines (NASDAQ: BPMC) reported Q2 EPS of ($2.68), $0.44 worse than the analyst estimate of ($2.24). Revenue for the quarter came in at $36.5 million versus the consensus estimate of $36.85 million.

For earnings history and earnings-related data on Blueprint Medicines (BPMC) click here.

... More